87810 Infectious agent antigen detection by immunoassay with direct optical observation; Chlamydia trachomatis

Name of the Procedure:

Infectious agent antigen detection by immunoassay with direct optical observation; Chlamydia trachomatis

Summary

This test, commonly known as a Chlamydia trachomatis antigen detection test, identifies the presence of Chlamydia trachomatis bacteria in your body. It's performed using an immunoassay which directly observes the reaction between the antigen (bacteria) and antibodies. It helps diagnose chlamydia infections.

Purpose

The test is used to diagnose an active infection with Chlamydia trachomatis, a common sexually transmitted infection (STI). The goal is to detect the bacteria to provide timely treatment and prevent complications, such as pelvic inflammatory disease, infertility, and transmission to sexual partners.

Indications

• Symptoms such as unusual genital discharge, burning during urination, or pain during intercourse.
• Screening in sexually active individuals, especially those with multiple partners.
• Follow-up testing after treatment for a previous chlamydia infection.
• Routine STI screening in pregnancy.

Preparation

• No special preparation is typically required.
• Patients may be advised to avoid urination for a specified period before the test to ensure sample quality.
• Abstaining from sexual activity 24 hours before the test may be recommended.

Procedure Description

1. A sample is collected, usually from the cervix in women and the urethra in men. It may also involve a urine sample.
2. The sample is sent to a laboratory where it is exposed to antibodies that will bind to the Chlamydia trachomatis bacteria if present.
3. A direct optical observation of the antigen-antibody reaction is conducted to confirm the presence of the bacteria.
4. Results are interpreted by a healthcare professional.

Duration

The sample collection takes about 5-10 minutes. Laboratory processing and analysis can take a few hours to a few days.

Setting

The sample collection is done in a healthcare setting such as a doctor's office, clinic, or hospital lab.

Personnel

• Medical technician or nurse collects the sample.
• Laboratory technicians or scientists analyze the samples.
• Physicians interpret the results and provide follow-up care.

Risks and Complications

• Minimal risk associated with the sample collection, such as mild discomfort or spotting.
• Rare chance of an infection at the sample collection site.

Benefits

• Accurate and prompt diagnosis of Chlamydia trachomatis.
• Facilitates timely treatment to avoid serious health complications.
• Reduces transmission risks to sexual partners.
• Results are typically available within a few days.

Recovery

• No specific recovery time.
• Patients can resume normal activities immediately after sample collection.
• Follow-up may be needed based on test results.

Alternatives

• Nucleic acid amplification tests (NAATs), generally more sensitive and specific.
• Culture tests, though they are more time-consuming and less commonly used.
• Pros of NAATs include higher accuracy, while cultures and immunoassays can be useful in certain diagnostic contexts or when resources are limited.

Patient Experience

• Mild discomfort during sample collection, especially for swabs.
• Minimal to no pain.
• Patients might feel anxious awaiting test results; reassurance and clear communication from healthcare providers can help.

Pain management and comfort measures include relaxing techniques and reassurance from medical staff during sample collection.